Cure Alzheimer’s Fund Research Grants support innovative, high-impact research projects advancing the understanding and treatment of Alzheimer’s disease.
Funder: Cure Alzheimer's Fund
Due Dates: Rolling (LOIs and proposals reviewed year-round)
Funding Amounts: Typical grant: $201,250/year (up to $175,000 direct + $26,250 indirect, 1–2 years)
Summary: Supports innovative research to advance understanding and treatment of Alzheimer’s disease, with emphasis on bold, translational, and high-impact science.
Key Information: Only LOIs from qualified researchers are considered; unsolicited full proposals are not accepted.
Cure Alzheimer’s Fund supports pioneering scientific investigations aimed at accelerating the development of a cure or disease-modifying therapies for Alzheimer’s disease. Grants are intended for research spanning foundational studies (genetics, biomarkers, epigenetics), translational research (novel genes, immune response, neurodegenerative pathways), drug discovery and enabling technologies, as well as preclinical and clinical drug development. The fund prioritizes high-impact, forward-thinking projects and emphasizes collaboration, openness, and sharing of results among its network of funded investigators. Projects must directly address Alzheimer’s disease, and preference is given to research with clear translational or therapeutic implications.